Antibodies News and Research

RSS

Research may lead to more accurate and reliable diagnostic test for autoimmune disease

In autoimmune diseases, the immune system wrongly identifies its "enemy", and produces antibodies that attack the patient's own cells.

14 Jun 2017

Researchers identify key Lassa virus structure using powerful Argonne X-rays

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus.

13 Jun 2017

Altered virus could help more patients to become eligible for human gene therapy trials

For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.

13 Jun 2017

Study finds that e-cigarettes are potentially as harmful as tobacco cigarettes in damaging DNA

A study by chemists at the University of Connecticut (UConn) offers new evidence that e-cigarettes loaded with a nicotine-based liquid are potentially as harmful as unfiltered cigarettes when it comes to causing DNA damage.

13 Jun 2017

Zika viral load not necessarily linked to pregnancy problems, fetal abnormalities

UCLA-led researchers have found that Zika viral load and the degree of Zika symptoms during pregnancy were not necessarily associated with problems during pregnancy or fetal abnormalities at birth.

13 Jun 2017

Common periodontal pathogen may delay conception in young women, study finds

According to a study carried out at the University of Helsinki, a common periodontal pathogen may delay conception in young women.

13 Jun 2017

UConn researchers find e-cigarettes to be equally harmful as tobacco cigarettes

A study by chemists at the University of Connecticut offers new evidence that electronic cigarettes or e-cigarettes are potentially as harmful as tobacco cigarettes.

12 Jun 2017

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.

8 Jun 2017

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.

8 Jun 2017

When an insurer balks and treatment stops

Gillen Washington, a student at Northern Arizona University, had been getting medication for an immunodeficiency disease since 2011. But when he went to his clinic in November 2014 for the monthly dose, a nurse told him his insurance company had denied it.

7 Jun 2017

Statin medications can cause necrotizing myopathy in some patients

Statin medications, such as Crestor, Lipitor, and other lipid-lowering medications, have been prescribed increasingly in recent years to reduce cardiovascular disease and mortality in high risk individuals.

6 Jun 2017

Anti-heroin vaccine developed at TSRI proven effective in primate models

A vaccine developed at The Scripps Research Institute (TSRI) to block the "high" of heroin has proven effective in non-human primates. This is the first vaccine against an opioid to pass this stage of preclinical testing.

6 Jun 2017

Obese people twice as likely to develop influenza despite getting flu shots

Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.

6 Jun 2017

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.

6 Jun 2017

Research shows new Zika virus vaccine that offers 100% protection in mice

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice.

5 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year - and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Antibodies News and Research

Research may lead to more accurate and reliable diagnostic test for autoimmune disease

Researchers identify key Lassa virus structure using powerful Argonne X-rays

Altered virus could help more patients to become eligible for human gene therapy trials

Study finds that e-cigarettes are potentially as harmful as tobacco cigarettes in damaging DNA

Zika viral load not necessarily linked to pregnancy problems, fetal abnormalities

Common periodontal pathogen may delay conception in young women, study finds

UConn researchers find e-cigarettes to be equally harmful as tobacco cigarettes

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

When an insurer balks and treatment stops

Statin medications can cause necrotizing myopathy in some patients

Anti-heroin vaccine developed at TSRI proven effective in primate models

Obese people twice as likely to develop influenza despite getting flu shots

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Research shows new Zika virus vaccine that offers 100% protection in mice

TSRI study reveals first-ever structure of Lassa virus protein

Researchers find new way to block type 1 diabetes

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

Cancer treatment may be effective therapy for psoriasis

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo